Physician

Edward A Stadtmauer, MD

According to 2025 Medicare claims, Edward Stadtmauer, MD (NPI: 1457394744) practices hematology in the Montgomery County-Bucks County-Chester County, PA market, with the plurality of this provider's patient population coming from Montgomery, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1679677975; TIN: 232743545) and primary practice location at 19104-5127.

Stadtmauer's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 379 traditional Medicare patients, billed 1,441 HCPCS/CPT codes, and received $145,012 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 886 prescription claims across 153 beneficiaries totaling $7,402,248 in drug costs, led by Pomalyst (Pomalidomide). 2023 DME data shows 26 claims. Open Payments data shows 20 records totaling $38,161. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $93,603 to $145,012. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $4,339,713 and ending at $7,402,248. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	305	1,072	$93,603
2016	314	1,179	$96,066
2017	331	1,236	$106,729
2018	380	1,262	$112,245
2019	373	1,449	$130,455
2020	333	1,109	$90,797
2021	338	1,228	$137,535
2022	369	1,364	$148,716
2023	387	1,384	$151,065
2024	379	1,441	$145,012

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	124	1,271	$4,339,713
2016	147	1,468	$5,312,603
2017	123	1,176	$5,200,647
2018	146	1,267	$5,983,978
2019	140	1,013	$5,738,528
2020	117	586	$3,597,615
2021	145	656	$3,699,484
2022	143	826	$7,216,415
2023	156	789	$5,678,569
2024	153	886	$7,402,248

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	38	$248,967
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	26	$304
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	16	16	$138
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	341	1,201	$110
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	34	79	$75
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	70	83	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Pomalyst	Pomalidomide	115	3,220	$2,479,374
Lenalidomide	Lenalidomide	181	5,068	$2,411,259
Revlimid	Lenalidomide	124	3,472	$2,354,523
Thalomid	Thalidomide	13	364	$99,315
Zarxio	Filgrastim-Sndz	18	78	$31,257

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	10	$6,932	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	10	$31,229	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Edward A. Stadtmauer, MD?

Tedicare shows public-source Medicare data for Edward A. Stadtmauer, MD (NPI 1457394744), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward A. Stadtmauer, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Edward A. Stadtmauer, MD?

Edward A. Stadtmauer, MD is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1679677975) in the available physician profile data.

Does Edward A. Stadtmauer, MD have Open Payments data?

Edward A. Stadtmauer, MD has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.